Pamabrom Capsule, Liquid Filled
NDC Package 70692-795-00

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Pamabrom capsules is a drug for further processing. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Strive Pharmaceuticals Inc, this product is identified by NDC 70692-795.

Identification & Billing

NDC Package Code
70692-795-00
Package Description
36000 CAPSULE, LIQUID FILLED in 1 BOX
Product Code
70692-795
11-Digit Billing Format
70692079500

Clinical Specifications

Proprietary Name
Pamabrom
Non-Proprietary Name
Pamabrom
Substance Name
Pamabrom
Dosage Form
Capsule, Liquid Filled - A solid dosage form in which the drug is enclosed within a soluble, gelatin shell which is plasticized by the addition of a polyol, such as sorbitol or glycerin, and is therefore of a somewhat thicker consistency than that of a hard shell capsule; typically, the active ingredients are dissolved or suspended in a liquid vehicle.
Active Ingredient(s)
PAMABROM 50 mg/1

Regulatory & Marketing

Labeler Name
Strive Pharmaceuticals Inc
Product Type
Drug For Further Processing
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
11-30-2020
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70692-795-00 identifies a specific commercial package of 36000 capsule, liquid filled in 1 box of Pamabrom (UNFINISHED drug), drug for further processing labeled by Strive Pharmaceuticals Inc. This capsule, liquid filled is formulated for use and contains pamabrom as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Strive Pharmaceuticals Inc on November 30, 2020. The current certification is valid through December 31, 2026.

How is this Strive Pharmaceuticals Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70692079500. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70692-795-00
11-Digit CMS (5-4-2)
70692-0795-00

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.